XML 35 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 20,012 $ 21,370 $ 62,914 $ 58,429
General and administrative 5,981 4,356 16,987 13,992
Total operating expenses 25,993 25,726 79,901 72,421
Loss from operations (25,993) (25,726) (79,901) (72,421)
Other income (expense):        
Interest income 419 776 843 2,961
Change in fair value of the tranche rights 0 0 0 (4,796)
Other income (expense), net (5) 582 1,186 (1,076)
Total other income (expense) 414 1,358 2,029 (2,911)
Net loss $ (25,579) $ (24,368) $ (77,872) $ (75,332)
Net loss per share, basic (in usd per share) $ (0.13) $ (0.24) $ (0.55) $ (0.75)
Net loss per share, diluted (in usd per share) $ (0.13) $ (0.24) $ (0.55) $ (0.75)
Weighted-average common shares outstanding, basic (in shares) 193,897,764 101,272,580 142,811,489 99,998,245
Weighted-average common shares outstanding, diluted (in shares) 193,897,764 101,272,580 142,811,489 99,998,245